Naproxen vs. Ibuprofen for Migraine: Which Is Better?

If you are reaching for an over-the-counter NSAID for a migraine, the question almost always comes down to naproxen versus ibuprofen. Both are widely available, both have decades of evidence in migraine treatment, and the literal answer to the question is "it depends on the attack." This piece walks through how to make that choice in practice.

The short version: ibuprofen is faster, naproxen lasts longer, and for most people the right answer depends on whether your attacks tend to come on hard and break quickly or come on slowly and drag.

How the two drugs differ pharmacologically

Both naproxen and ibuprofen are non-selective NSAIDs. They both block COX-1 and COX-2 enzymes, which reduces prostaglandin production and dampens the trigeminal-nerve inflammation involved in migraine. From a mechanism perspective they are doing the same job. The differences are in pharmacokinetics:

• Onset. Ibuprofen reaches peak plasma concentration in about 1 to 2 hours; naproxen takes 1 to 4 hours, with the sodium-salt form (Aleve) at the faster end.
• Half-life. Ibuprofen is short — 2 to 4 hours. Naproxen is long — 12 to 17 hours.
• Dose form. Ibuprofen comes in liquid gel and dissolved-tablet versions that absorb noticeably faster than standard tablets. Naproxen has no equivalent fast-absorbing form.

That difference in half-life is the entire ballgame. One short dose of ibuprofen covers a few hours. One dose of naproxen covers most of a working day.

Effectiveness for migraine

In clinical trials, the two are roughly comparable for 2-hour pain relief in mild-to-moderate attacks. Specifically:

• Ibuprofen 400 to 600 mg: 2-hour pain relief in about 40 to 50 percent of attacks, pain-freedom in about 25 percent. Faster onset is the practical advantage.
• Naproxen 500 to 825 mg: 2-hour pain relief in about 45 to 50 percent of attacks, pain-freedom in about 20 percent. Longer duration is the practical advantage.

Neither matches a triptan for acute response in moderate-to-severe attacks. Both are useful for mild attacks and as the NSAID half of a combination strategy with a triptan.

When ibuprofen wins

Reach for ibuprofen when:

• The attack is escalating fast and you need onset in 30 to 60 minutes.
• The attack tends to be short — under 6 hours. The 4-hour duration of one ibuprofen dose covers most of it.
• You want flexibility on the timing of the next dose. You can re-dose every 4 to 6 hours if needed.
• The attack is mild and you want the shortest exposure to NSAID side effects.
• You can take the liquid gel form, which absorbs faster than standard tablets.

A common ibuprofen-for-migraine dose: 400 to 600 mg at attack onset, repeating 400 mg every 6 hours as needed up to 2400 mg per day for short courses.

When naproxen wins

Reach for naproxen when:

• The attack is long — 8 hours or more. The 12-hour half-life covers it with one dose.
• The attack is recurrence-prone. Migraines that come back later the same day after a triptan benefit from a long-acting NSAID alongside.
• You are using it as menstrual-migraine prophylaxis, taking it twice daily over a 5-to-7-day high-risk window. The twice-daily schedule fits the half-life.
• You have cardiovascular risk factors. Naproxen carries the lowest cardiovascular risk of the NSAIDs, modestly lower than ibuprofen.
• You are combining with a triptan — Treximet (sumatriptan plus naproxen) is the fixed-dose product that captures this benefit.

A common naproxen-for-migraine dose: 500 to 825 mg at attack onset, with a possible repeat of 250 to 500 mg 8 to 12 hours later if needed.

Side-effect comparison

Both share the NSAID side-effect profile — GI upset, GI bleeding risk, kidney injury risk, mild blood pressure elevation, fluid retention — but the magnitude differs slightly:

• GI bleeding risk. Roughly comparable per dose. Naproxen's longer half-life means cumulative exposure adds up faster with daily use; ibuprofen's shorter duration means more re-dosing.
• Cardiovascular risk. Long-term high-dose ibuprofen modestly raises cardiovascular event rates; naproxen does not. For people with cardiovascular disease who still need an NSAID, naproxen is the preferred choice.
• Kidney injury. Comparable. Both raise the risk in dehydrated, elderly, or chronic-kidney-disease patients.
• Blood pressure. Both raise it about 3 to 5 mmHg.
• Drug interactions. Largely the same — both interact with anticoagulants, ACE inhibitors and ARBs, lithium, and SSRIs.

What headache specialists actually recommend

In practice, most headache specialists will suggest a personal answer rather than a population answer:

1. Try one for three or four attacks at the right dose and the right timing.
2. If it does the job and the side effects are tolerable, that is your NSAID.
3. If it does not, try the other.

Most people end up settling on one of the two based on attack length and personal response. About 70 percent of patients find one NSAID clearly works better for them than the other, but which one varies. The pattern that tracks best with naproxen preference is long attacks and recurrence; the pattern that tracks best with ibuprofen preference is short, fast-escalating attacks where time-to-onset matters.

The combination angle

Neither drug alone matches a triptan for moderate-to-severe attacks. But pairing either NSAID with a triptan outperforms the triptan alone. For people who experience late recurrence after a triptan, the long-acting NSAID — naproxen — pairs better than ibuprofen. For people whose triptan works fast but who want extra coverage in the first few hours, either works.

Where pressure tracking fits

Both NSAIDs reward early dosing, and for weather-sensitive people the pressure drop often comes first. Pressure Pal works as a migraine tracker app that flags barometric pressure changes ahead of time, and logging which attacks responded better to naproxen versus ibuprofen versus a triptan helps you and your doctor see your own pattern over a few months rather than guessing in the moment.